Stueland Katherine
SEC insider (Form 3/4/5 filer). CIK 0001689575. CHIEF EXECUTIVE OFFICER at GeneDx Holdings Corp. (WGS). 140 reported Form 4/5 transactions since Sep 2024; latest on Sep 16, 2026. Located in STAMFORD, CT.
Companies Stueland Katherine has filed insider reports for
- GeneDx Holdings Corp. (WGS): Director, Officer, CHIEF EXECUTIVE OFFICER
Stueland Katherine
CIK: 0001689575
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
GeneDx Holdings Corp.
Discretionary Trading P&L
Holdings
Transaction History (140 total)
- Sep 16, 2026WGS
GeneDx Holdings Corp.
SaleDirect148 shares at avg. $95.41$14K - Sep 16, 2026WGS
GeneDx Holdings Corp.
SaleDirect1.6K shares at avg. $94.26$155K - Sep 16, 2026WGS
GeneDx Holdings Corp.
SaleDirect4.1K shares at avg. $98.27$407K - Sep 16, 2026WGS
GeneDx Holdings Corp.
SaleDirect1.5K shares at avg. $96.90$148K - Sep 16, 2026WGS
GeneDx Holdings Corp.
ExerciseDirect18.8K shares- - Sep 16, 2026WGS
GeneDx Holdings Corp.
SaleDirect3K shares at avg. $99.00$301K - Sep 9, 2026WGS
GeneDx Holdings Corp.
ExerciseDirect6.5K shares- - Sep 9, 2026WGS
GeneDx Holdings Corp.
SaleDirect3.7K shares at avg. $84.22$311K - Jun 16, 2026WGS
GeneDx Holdings Corp.
SaleDirect5.9K shares at avg. $60.83$361K - Jun 16, 2026WGS
GeneDx Holdings Corp.
SaleDirect2.4K shares at avg. $61.50$149K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 16, 2026 | WGS GeneDx Holdings Corp. | Sale | 148 | $95.41 | $14,120 | Direct |
| Sep 16, 2026 | WGS GeneDx Holdings Corp. | Sale | 1,648 | $94.26 | $155,337 | Direct |
| Sep 16, 2026 | WGS GeneDx Holdings Corp. | Sale | 4,141 | $98.27 | $406,936 | Direct |
| Sep 16, 2026 | WGS GeneDx Holdings Corp. | Sale | 1,525 | $96.90 | $147,774 | Direct |
| Sep 16, 2026 | WGS GeneDx Holdings Corp. | Exercise | 18,750 | - | $0 | Direct |
| Sep 16, 2026 | WGS GeneDx Holdings Corp. | Sale | 3,039 | $99.00 | $300,846 | Direct |
| Sep 9, 2026 | WGS GeneDx Holdings Corp. | Exercise | 6,547 | - | $0 | Direct |
| Sep 9, 2026 | WGS GeneDx Holdings Corp. | Sale | 3,692 | $84.22 | $310,932 | Direct |
| Jun 16, 2026 | WGS GeneDx Holdings Corp. | Sale | 5,932 | $60.83 | $360,838 | Direct |
| Jun 16, 2026 | WGS GeneDx Holdings Corp. | Sale | 2,429 | $61.50 | $149,392 | Direct |
1-10 of 140 transactions